Investor Presentation

113 Investor presentation First six months of 2022 Diabetes market share and market growth in EMEA EMEA Diabetes market growth and Novo Nordisk market share Diabetes market size and growth DKK billion ~14% 75% 20% 18% 5 106 3 5 93 14% 15% 50% 25% 36% 10% 29% 5% 28% ~18% 29% 0% May 2022 May 2021 Novo Nordisk AZ Others May 2022 Novo Nordisk Competitors 0% May 2019 NN market share Market growth (right axis) NN share of growth NN growth (right axis) Source: IQVIA, May 2022, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; AZ- Astra Zeneca

View entire presentation